References
- Pfeiffer E, Verwoerdt A, Davis GC. Sexual behav-ior in middle life. Am J Psychiatry 1972;128: 1262–7
- Labrie F, Belanger A, Cusan L, Gomez J-L, Candas B. Marked decline in serum concentra-tions of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Gun Endocrinol Metab 1997;82: 2396–402
- Judd HL, Judd GE, Lucas WE, Yen SSC. Endo-crine function of the postmenopausal ovary: con-centration of androgens and estrogens in ovarian and peripheral vein blood. J Gun Endocrinol Metab 1974;39:1020–4
- Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replace-ment therapy — effects on sexual life, psychologi-cal well-being and androgen status. J Psychosom Obstet Gynecol 1993;14:283–93
- Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in female: a prospec-tive, crossover study of sex steroid administration in surgical menopause. Psychosom Med 1985;47: 339–51
- Castelo-Branco C, Vicente JJ, Figueras F, et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid patterns and sexuality in postmenopausal women. Maturitas 2000;34: 161–8
- van der Vies J. Pharmacological studies with (7,17)-17-hydroxy-7-methyl-19-nor pregn-5(10) -en-20-yn-3-one (Org 0D14). Maturitas 1987; Suppl 1:15–24
- Palacios S, Menendez C, Jurado AR, Castano R, Vargas JC. Changes in sex behaviour after meno-pause: effects of tibolone. Maturitas 1995;22: 155–61
- Rymer J, Chapman MG, Fogelman I, Wilson POG. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994;18:127–33
- Greene JG, Hart DM. Evaluation of a psychologi-cal treatment programme for climacteric women. Maturitas 1987;9:41–8
- Ulrich LG, Barlow DH, Sturdee DW, et al. Quality of life and patient preference for sequen-tial versus continuous combined HRT: the UK Kliofem multicenter study experience. Int J Gynaecol Obstet 1997;59(Suppl 1):s11–17
- Nathorst-Boos J, Wiklund I, Mattson LA, et al. Is sexual life influenced by transdermal estrogen therapy — a double blind controlled study in post-menopausal women. Acta Obstet Gynecol Scand 1992;72:656–60
- Nathorst-Boos J, Hammar M. Effect on sexual life — a comparison between tibolone and a continuous estradiol—norethisterone acetate regimen. Maturitas 1997;26:15–20
- Meuwissen JHJM, Wiegerinck MAHM, Haverkorn MJ. Regression of endometrial thick-ness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replace-ment therapy. Maturitas 1995;21:121–5
- Bjarnason NH, Bjarnason K, Haarbo J, Bennink HJ, Christiansen C. Tibolone: influence on markers of cardiovascular disease. J Clin Endo-crinol Metab 1997;82:1752–6
- Matthews KA, Wing RR, Kuller LH, et al. Influ-ences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J Consult Clin Psycbol 1990;58: 345–51
- Campagnoli C, Biglia N, Altare F, et al. Differen-tial effects of oral conjugated estrogens and trans-dermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol 1993; 7:251–8
- Pridjian G, Schmit V, Schreiber J. Medroxy-progesterone acetate receptor binding and corre-lated effects on steroidogenesis in rat granulosa cells. J Steroid Biocbem 1987;26:313–19